More info
Novel bidentate-galactose prodrug of W-105 (AOB12604), releasing the antitumor pharmacophore in the presence of GSH (mimic the condition of the tumor cell) and maintaining the low-toxic structures in the absence of GSH (mimic the condition of the normal cell)